Showing results (571-580 of 3,353) with videos related to

Sort By:
Pageof 336
The Lancet. Oncology|June 11, 2016
Dabrafenib plus trametinib in patients with previously treated BRAF(V600E)-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trialDavid Planchard, Benjamin Besse, Harry J M Groen, et al.
The Lancet. Oncology|June 11, 2016
Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trialJoan E Walter, Marjolein A Heuvelmans, Pim A de Jong, et al.
The Lancet. Oncology|June 11, 2016
Quality of life in patients with advanced renal cell carcinoma given nivolumab versus everolimus in CheckMate 025: a randomised, open-label, phase 3 trialDavid Cella, Viktor Grünwald, Paul Nathan, et al.
The Lancet. Oncology|May 9, 2016
Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trialGillian M Duchesne, Henry H Woo, Julie K Bassett, et al.
The Lancet. Oncology|May 10, 2016
Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trialKei Muro, Hyun Cheol Chung, Veena Shankaran, et al.
The Lancet. Oncology|December 7, 2017
European position statement on lung cancer screeningMatthijs Oudkerk, Anand Devaraj, Rozemarijn Vliegenthart, et al.
The Lancet. Oncology|December 9, 2017
Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trialManish R Patel, John Ellerton, Jeffrey R Infante, et al.
The Lancet. Oncology|November 15, 2017
Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study GroupDennis A Eichenauer, Annette Plütschow, Stefanie Kreissl, et al.
The Lancet. Oncology|September 6, 2017
Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation studyNico van Zandwijk, Nick Pavlakis, Steven C Kao, et al.
The Lancet. Oncology|September 9, 2017
Definition and recommendations for advance care planning: an international consensus supported by the European Association for Palliative CareJudith A C Rietjens, Rebecca L Sudore, Michael Connolly, et al.
Pageof 336